Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results
PositiveFinancial Markets

Erste Group has upgraded its rating for Eli Lilly to 'Buy' following the company's impressive first half results. This upgrade reflects confidence in Eli Lilly's strong performance and growth potential, which is significant for investors looking for promising stocks in the pharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System